fibronostics Profile Banner
Fibronostics Profile
Fibronostics

@fibronostics

Followers
752
Following
386
Media
158
Statuses
367

Mitigating risk by detecting undiagnosed disease through non-invasive, algorithm-based diagnostics.

United States
Joined January 2018
Don't wanna be here? Send us removal request.
@fibronostics
Fibronostics
6 years
A recent study shows that patients with severe COVID-19 are at higher risk of liver dysfunction. #COVID19 #Liver #undiagnosed https://t.co/sosUxzGCJs
0
1
3
@AASLDtweets
AASLD
6 years
AASLD has created "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic" It provides data on #COVID19, & how it may affect hepatologists & liver transplant providers & their patients. Read it: https://t.co/J2dj8Dr9ur #LiverTwitter #LTx
0
58
74
@fibronostics
Fibronostics
6 years
Take a look at the papers and oral presentations presented at the NASH-TAG Conference. @NashTagConf #nash
@NashTagConf
NASH-TAG Conference
6 years
πŸ†• Free papers (orals or posters) and selected oral presentations presented at NASH-TAG can now be cited! Learn more: https://t.co/6SzwUQsNm0 #nash
0
2
4
@NashTagConf
NASH-TAG Conference
6 years
🌎 #Liver History: "The first acknowledged case of obesity-related non-alcoholic fatty liver was observed in 1952 by Samuel Zelman." β€” @JAMAInternalMed #NAFLD #NASH
0
4
14
@fibronostics
Fibronostics
6 years
Read the latest from @HEP_Journal "Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology"
@AASLDtweets
AASLD
6 years
From @HEP_Journal: "Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology" https://t.co/xzI0X3zolS #AASLDjournals #NAFLD
0
0
0
@fibronostics
Fibronostics
6 years
Take a look at abstracts from @NashTagConf past conferences.
@NashTagConf
NASH-TAG Conference
6 years
Review these #NASH abstract books from 2017 - 2020! ⛰️ https://t.co/8FV8tpZzAR
1
1
1
@fibronostics
Fibronostics
6 years
According to the United Nations data, less than 30% of scientific researchers worldwide are women. https://t.co/FeB16WVQlK #IWD2020 #InternationalWomensDay
0
1
2
@AASLDtweets
AASLD
6 years
From @CLD_Learning: "60 Days in Biliary Atresia: A Historical Dogma Challenged" https://t.co/TaXJUcg6FD #AASLDjournals #BA #LiverTwitter
0
2
6
@fibronostics
Fibronostics
6 years
It is estimated that obesity is linked to more than 60 chronic diseases. #obesity #WorldObesityDay
@WHO
World Health Organization (WHO)
6 years
Today is #WorldObesityDay. Worldwide obesity has nearly tripled since 1975. Most of the 🌎🌍🌏's population live in countries where overweight & obesity kills more people than underweight. Obesity is PREVENTABLE and TREATABLE. https://t.co/oeuauqWru6
0
1
2
@fibronostics
Fibronostics
6 years
In a recent study, researchers find an alarming increase of #NAFLD in young adults. #liverdisease #fattyliver https://t.co/nManlFNdeo
0
0
1
@fibronostics
Fibronostics
6 years
The results of a recent study report adults aged 25 to 34 experienced the highest average annual increase in cirrhosis-related deaths of any age group from 2009 to 2016. #liverdisease #cirrhosis
0
0
1
@fibronostics
Fibronostics
6 years
Researchers discover mobile stroke units offer patients care a half-hour faster than when patients are transported to a hospital by a traditional ambulance. #stroke
heart.org
Specially outfitted vehicles with lifesaving equipment can provide care to stroke patients faster, according to a new study.
0
0
1
@fibronostics
Fibronostics
6 years
Doctors are reporting an increase of patients who are in their 20's and 30's with symptoms of acute liver disease. #liverdisease
@mellonpost
Mellonpost
6 years
Alcoholic liver disease rates soar among younger people - https://t.co/JEObLty3ES
0
2
2
@fibronostics
Fibronostics
6 years
Researchers test the efficacy of nor-urso in the treatment of #NAFLD. https://t.co/9SL7kfYucn #fattyliver #liverdisease
0
1
4
@HenryEChang
Henry E. Chang
6 years
Prof Brent Neuschwander-Tetri provides a comprehensive overview of the therapeutic landscape for #NAFLD #NASH in 2020 with a focus on drugs in advanced clinical development→ https://t.co/xK9y1qj9bk @AGA_Gastro @AmerGastroAssn
0
6
15
@fibronostics
Fibronostics
6 years
A recent study reports participants who consume low levels of sulphur amino acids (15kg-24kg a day) have significantly lower levels of cholesterol, glucose and insulin – and lower overall risk of cardiometabolic diseases.
@ConversationUK
The Conversation
6 years
People who eat higher amounts of sulphur amino acids – found more commonly in meat – were at increased risk of developing heart disease, stroke, diabetes, and non-alcohol fatty liver disease.
0
0
0
@fibronostics
Fibronostics
6 years
Take a look at this recent article titled, Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. #nash #nafld
@NashTagConf
NASH-TAG Conference
6 years
πŸ†• #NASH NEWS πŸ“° Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. Read more: https://t.co/skVsQRBZEt @nresearchnews #meded
0
1
1
@AASLDtweets
AASLD
6 years
JOIN THE CONVERSATION There's a great discussion around Alcohol Free Beer taking place in Engage, AASLD's online community. Have something to contribute to the conversation? Check it out πŸ‘‰ https://t.co/r3FRW9DeFF #MemberBenefit #AlcoholFreeBeer #ALDsig
0
1
7